Ferguson Wellman Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ferguson Wellman Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,410	Closed	-$240K	–	367
2020 Q3	$240K	Hold	4,410	–	–	0.01%	319
2020 Q2	$226K	Sell	4,410 -1,860	-30%	-$93.5K	0.01%	312
2020 Q1	$281K	Sell	6,270 -1,740	-22%	-$87.8K	0.01%	271
2019 Q4	$428K	Sell	8,010 -240	-3%	-$11.8K	0.01%	278
2019 Q3	$385K	Sell	8,250 -2,580	-24%	-$124K	0.01%	280
2019 Q2	$544K	Sell	10,830 -8,580	-44%	-$424K	0.02%	244
2019 Q1	$996K	Sell	19,410 -12,240	-39%	-$609K	0.03%	200
2018 Q4	$1.49M	Buy	+31,650	New	+$1.62M	0.06%	188

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Ferguson Wellman Capital Management's IHE Position: Q4 2020 in Review

Ferguson Wellman Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2020, closing a stake of 4,410 shares — an estimated $240K sold.

Ferguson Wellman Capital Management first reported a position in IHE in Q4 2018 and held it in 8 quarters. The position peaked at $1.49M in Q4 2018. 99 funds tracked by Wall St. Rank hold IHE as of Q4 2020.

Ferguson Wellman Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2020 after selling out during the quarter.
Ferguson Wellman Capital Management sold 4,410 iShares US Pharmaceuticals ETF shares in Q4 2020, an estimated $240K.
Ferguson Wellman Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2018 and held it in 8 quarters.
Ferguson Wellman Capital Management's iShares US Pharmaceuticals ETF position peaked at $1.49M in Q4 2018.
99 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2020.

Based on Ferguson Wellman Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.